Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)
Titel:
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)
Auteur:
Albala, David Manak, Michael S. Varsanik, Jonathan S. Rashid, Hani H. Mouraviev, Vladimir Zappala, Stephen M. Ette, Ene Kella, Naveen Rieger-Christ, Kimberly M. Sant, Grannum R. Chander, Ashok C.